Wilson Sonsini Goodrich & Rosati advised Novo Holdings on the transaction. Magenta Medical (Magenta) announced that it has raised $105 million in financing. The financing was...
Magenta Medical’s $105 Million Financing Round
Alida Biosciences’ $7.5 Million Series A Financing Round
Wilson Sonsini Goodrich & Rosati advised Genoa Ventures on patent matters related to the transaction. Alida Biosciences (AlidaBio), an innovator in epigenomic research tools, announced it...
Novo Holdings’ Acquisition of Majority Stake in Single Use Support
DORDA, Kromann Reumert and Linklaters advised Novo Holdings A/S on the transaction. Wilson Sonsini Goodrich & Rosati advised Novo Holdings on IP Matters. Novo Holdings A/S...
Foresight Diagnostics’ Partnership with Allogene Therapeutics
Wilson Sonsini Goodrich & Rosati advised Foresight Diagnostics on the transaction. Allogene Therapeutics Inc. (Nasdaq: ALLO) and Foresight Diagnostics, announced a strategic partnership to develop a minimal residual...
Arcellx’s Expansion of Partnership with Kite
Wilson Sonsini Goodrich & Rosati is advising Arcellx on the transaction. Arcellx, Inc. (NASDAQ: ACLX) and Kite, a Gilead Company (NASDAQ: GILD) announced that they have...
MapLight Therapeutics’ $225 Million Series C Funding Round
Wilson Sonsini Goodrich & Rosati advised Novo Holdings on the transaction. MapLight Therapeutics announced a $225 million Series C financing co-led by Novo Holdings, 5AM Ventures, Cowen...
Cyclo Therapeutics’ Acquisition of Applied Molecular Transport
Fox Rothschild LLP is acting as legal advisor to Cyclo Therapeutics and Wilson Sonsini Goodrich & Rosati, P.C. is acting as legal advisor to Applied Molecular...
L Catterton’s $680 Million Acquisition of Thorne HealthTech
Kirkland & Ellis LLP is representing L Catterton, and Wilson Sonsini Goodrich & Rosati is representing Thorne HealthTech, Inc. in the transaction. Thorne HealthTech, Inc. (“Thorne”)...
Foresight Diagnostics’ $58.75 Million Series B Financing Round
Wilson Sonsini Goodrich & Rosati advised Foresight on the deal. Foresight Diagnostics, Inc, a leading developer of ultrasensitive cancer detection tests, announced the close of an...
EVERY’s $175 Million Series C Financing
Wilson Sonsini Goodrich & Rosati advised EVERY on the deal while Pillsbury Winthrop Shaw Pittman represented McWin. The EVERY Company, the leading precision fermentation platform accelerating a...
Hexagon Bio’s $61 Million Funding Round
Wilson Sonsini Goodrich & Rosati advised Hexagon Bio on the deal. Hexagon Bio, a biopharmaceutical company pioneering the discovery of medicines encoded in the global metagenome,...
80 Acres Farms’ $160 Million Series B Funding Round
Wilson Sonsini Goodrich & Rosati advised Siemens Financial Services, Inc. on the deal. Acres Farms, an industry-leading vertical farming company, secured $160 million in additional funding...